Literature DB >> 11211884

Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy.

T Fukutomi1, M Nakamuta, M Fukutomi, M Iwao, H Watanabe, K Hiroshige, Y Tanabe, H Nawata.   

Abstract

BACKGROUND/AIMS: Hepatitis C virus (HCV) kinetics during interferon (IFN)-alpha treatment have been evaluated recently, however, little is known about the resultant viral kinetics in IFN-beta treatment. In this study, we evaluated HCV kinetics during the first 24 h of IFN-beta treatment, and also assessed their relationship to therapeutic outcomes.
METHODS: We measured HCV RNA levels at 0 and 24 h after the initiation of IFN-beta treatment, and we calculated the decay slope, viral half-life, and viral production and clearance. Then we analyzed these factors as they related to therapeutic responses with IFN-beta as well as to clinical variables, i.e. genotype, diversity of hyper variable region, and histological findings.
RESULTS: Patients with sustained responses (SR) displayed steeper decay slopes of the viral load than those without SR (2.87 +/- 1.41 vs. 1.82 +/- 1.66, P = 0.031). On the other hand, the decay slope was not affected by the clinical variables. The values of viral half-life and viral production and clearance showed no significant correlation to the response and the clinical variables.
CONCLUSION: This study demonstrated that the decay slope of the viral load during the first 24 h is related to the virological response to IFN-beta treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211884     DOI: 10.1016/s0168-8278(00)00044-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

Review 1.  Is interferon-beta an alternative treatment for chronic hepatitis C?

Authors:  Ricardo Moreno-Otero; María Trapero-Marugán; Elena Gómez-Domínguez; Luisa García-Buey; José A Moreno-Monteagudo
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

2.  Response prediction and treatment tailoring for chronic hepatitis C virus genotype 1 infection.

Authors:  Magnus Lindh; Erik Alestig; Birgitta Arnholm; Anders Eilard; Kristoffer Hellstrand; Martin Lagging; Thomas Wahlberg; Rune Wejstål; Johan Westin; Gunnar Norkrans
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

3.  Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients.

Authors:  Denis Ouzan; Hacène Khiri; Guillaume Pénaranda; Hélène Joly; Philippe Halfon
Journal:  Comp Hepatol       Date:  2005-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.